Assessment of Provider Utilization Through Skin Biopsy Rates
BACKGROUNDThere have been recent claims of overdiagnosis and unnecessary treatment in dermatology. One potential manifestation of overutilization would be providers who perform numerous biopsies per patient. OBJECTIVETo identify the frequency of skin biopsy rate outliers. MATERIALS AND METHODSData o...
Gespeichert in:
Veröffentlicht in: | Dermatologic surgery 2019-08, Vol.45 (8), p.1035-1041 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | BACKGROUNDThere have been recent claims of overdiagnosis and unnecessary treatment in dermatology. One potential manifestation of overutilization would be providers who perform numerous biopsies per patient.
OBJECTIVETo identify the frequency of skin biopsy rate outliers.
MATERIALS AND METHODSData on biopsy rates at the individual provider level were obtained from Medicare Provider Utilization and Payment Data Public Use Files. The total number of biopsies for each provider was obtained by summing the number of claimed biopsy services for each unique National Provider Identifier. The visit count for each provider was obtained by summing all evaluation and management services claimed. Provider biopsy rates were calculated by dividing the total number of biopsies associated with each National Provider Identifier by the corresponding visit count.
RESULTSThe mean provider biopsy rate was 0.31 services per visit, or approximately 1 biopsy every 3 visits. Defining outliers as providers who averaged 3 or more biopsies per visit, there were 38 outliers out of 18,260 providers. Physicians had a lower mean biopsy rate than nonphysician clinicians (p = 1.70E–28).
CONCLUSIONContrary to claims, the authorsʼ results do not indicate widespread overutilization of skin biopsy services. |
---|---|
ISSN: | 1076-0512 1524-4725 |
DOI: | 10.1097/DSS.0000000000001763 |